molecalculator

Moles & Molar Mass

How Long Has mRNA Been Around? History & Facts

Calculator No. 01-11611 · Updated · Formula and assumptions shown below

Molarity 0.2000 mol/L
Concentration in millimolar
200.00 mM
= Molarity × 1000
Mass of solute
2.922 g
Set in the form below
Molar mass
58.44 g/mol
Set in the form below
You enter
Mass of solute (g), Molar mass (g/mol), Final solution volume (mL)
You get
Molarity (mol/L), Concentration in millimolar (mM)
Rounding
4 dp · 2 dp

For study and lab planning. The result follows from the numbers you enter and the formula shown. Check it against your method before you weigh, mix or dilute anything, follow the safety data sheet and your supervisor, and do not use it for clinical, dosing or medication work.

mRNA has been around as a scientific concept since 1961, when it was first discovered, and as a therapeutic technology since the early 1990s. In practical terms, the first mRNA vaccines were approved for human use in 2020, but the underlying research and development span over six decades.

Formula

The molarity (c) is calculated as the amount of solute in moles divided by the volume of solution in liters. The formula is:

c = m / (M × V)

Where:

  • c = molarity (mol/L)
  • m = mass of solute (g)
  • M = molar mass of solute (g/mol)
  • V = volume of final solution (L, converted from mL by dividing by 1000)

Worked Example

Using the default values: mass of NaCl = 2.922 g, molar mass = 58.44 g/mol, volume = 250 mL.

First, convert volume to liters: 250 mL ÷ 1000 = 0.250 L

Then calculate moles of solute: 2.922 g ÷ 58.44 g/mol = 0.05000 mol

Finally, molarity = 0.05000 mol ÷ 0.250 L = 0.2000 mol/L

The calculator gives 0.2000 mol/L (or 200.0 mM).

Assumptions

  • The solute is pure and fully dissolved.
  • The final volume is the total volume of the solution, not the volume of solvent added.
  • The density of the solution is assumed to be close to that of water (for dilute solutions).

Background: The Discovery of mRNA (1960s)

The story of mRNA begins in 1961, when François Jacob and Jacques Monod proposed the existence of a short-lived molecule that carries genetic information from DNA to ribosomes, where proteins are made. Later that year, Sydney Brenner, François Jacob, and Matthew Meselson experimentally confirmed the existence of mRNA in bacteria. This discovery earned Jacob and Monod the Nobel Prize in Physiology or Medicine in 1965 (shared with André Lwoff).

For decades, mRNA was studied as a fundamental biological molecule, but its instability and the body’s immune response to foreign RNA made it seem impractical for medicine. Yet researchers kept working on ways to use mRNA to instruct cells to produce therapeutic proteins or antigens.

Early Therapeutic Research (1990s–2000s)

The first successful use of mRNA to express a protein in living animals was reported in 1990, when researchers injected mRNA encoding luciferase into mice and observed the protein being produced. This proof-of-concept sparked interest in mRNA as a therapeutic tool.

In the late 1990s and early 2000s, scientists began developing methods to modify mRNA to reduce its immunogenicity and improve its stability. A key breakthrough came in 2005 when Katalin Karikó and Drew Weissman published work showing that modified nucleosides (such as pseudouridine) could prevent mRNA from triggering a strong inflammatory response. This discovery was essential for making mRNA safe for therapeutic use and was later recognized with the 2023 Nobel Prize in Physiology or Medicine.

How mRNA Vaccines Work

mRNA vaccines work by delivering a piece of genetic code that instructs cells to produce a specific antigen (a protein from a pathogen). The immune system then recognizes that antigen as foreign and develops a memory response. When the real pathogen is encountered, the immune system is ready to fight it.

The mRNA is packaged in lipid nanoparticles (LNPs) to protect it from degradation and help it enter cells. Once inside, the mRNA is translated into the antigen protein, then the mRNA is naturally broken down. This is why mRNA vaccines do not alter your DNA – they only provide temporary instructions.

From Concept to COVID-19 Vaccines (2010s–2020)

Before 2020, no mRNA vaccine had been approved for human use, but clinical trials for mRNA vaccines against rabies, influenza, and cytomegalovirus were underway. The COVID-19 pandemic accelerated development dramatically. In December 2020, the Pfizer-BioNTech and Moderna mRNA vaccines received emergency use authorization, marking the first time mRNA vaccines were approved for humans. This was a remarkable achievement, with development and testing compressed into less than a year.

The success of these vaccines demonstrated that mRNA technology could be rapidly adapted to new pathogens, sparking interest in mRNA vaccines for other diseases like HIV, Zika, and certain cancers.

Common Misconceptions

One common misconception is that mRNA vaccines alter your DNA. This is false – mRNA never enters the nucleus where DNA resides, and it is degraded after protein production. Another misconception is that mRNA is a new technology invented for COVID-19. As we’ve seen, the science has been developing for over 60 years.

Some people worry about the long-term effects of mRNA vaccines, but the mRNA itself lasts only a few days in the body, and the immune response is similar to that from a natural infection. The technology has been studied for decades, and the rapid rollout was due to enormous funding and collaboration, not lack of prior research.

Frequently Asked Questions

How long does mRNA stay in your body? mRNA from vaccines is typically broken down within a few days after injection. The lipid nanoparticles are cleared by the liver, and the mRNA is degraded by cellular enzymes. The proteins produced from mRNA may persist for a few weeks, but the mRNA itself is short-lived.

Was mRNA used in vaccines before COVID-19? No, COVID-19 was the first time mRNA vaccines were authorized for human use. However, mRNA vaccines had been tested in clinical trials for other diseases like rabies and influenza, and the technology had been under development for decades.

Why did it take so long to develop mRNA vaccines? The main challenges were making mRNA stable enough, reducing its inflammatory effects, and developing safe delivery systems. The 2005 discovery of modified nucleosides was a turning point, but it took years of additional research and funding to translate that into viable vaccines.

Can mRNA be used for other diseases? Yes, mRNA technology is being researched for cancer immunotherapy (where it teaches the immune system to attack tumor cells), and for vaccines against HIV, Zika, and other infectious diseases. It may also be used for protein replacement therapies.

Is mRNA natural? mRNA is a natural molecule that exists in all living cells. The mRNA used in vaccines is synthesized in a lab but is chemically identical to natural mRNA, except for some modifications that make it more stable and less inflammatory.

Does mRNA technology have a future beyond vaccines? Absolutely. Researchers are exploring mRNA for gene editing, regenerative medicine, and even allergy treatments. The platform is highly versatile because it can be programmed to produce almost any protein.

Related

Formula used
in m | Mass of solute | g | 2.922 | 0
in mm | Molar mass | g/mol | 58.44 | 0.001
in v | Final solution volume | mL | 250 | 0.001
out c | Molarity | mol/L | m / mm / (v / 1000) | 4
out cmm | Concentration in millimolar | mM | c * 1000 | 2

Each line is one input (in, sel, list) or one result (out: label, unit, formula, decimals). How the calculators work

Method: the standard formula for this calculation with the constants and conversion factors written on the page, rounded as each result states. See method and constants, the disclaimer or report an error.

More in this section

The whole Moles & Molar Mass section →